SolviMeda - Company finances
|
EUR
|
2022
From: 2022-10-27
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | 0 | 348,711 | 973,726 | 1,638,698 |
| Profit before tax | - | 84,038 | 127,702 | 103,081 |
| Net profit | 0 | 71,093 | 127,702 | 98,792 |
| Equity | 2,500 | 73,593 | 194,240 | 260,091 |
| Liabilities | 0 | 64,611 | 157,440 | 393,089 |
| Non-current assets | 0 | 0 | 174,987 | 279,108 |
| Current assets | 2,500 | 138,204 | 176,693 | 373,632 |
| Total assets | 2,500 | 138,204 | 351,680 | 652,740 |
|
Taxes paid
|
||||
| STI taxes | - | 29,767 | 147,142 | 206,334 |
| Social insurance contributions | - | 44,776 | 141,051 | 249,168 |
|
Financial indicators
|
||||
| Revenue change y/y | - | - | +179.2% | +68.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | 51.4% | 36.3% | 15.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.0% | 96.6% | 65.7% | 38.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | 20.4% | 13.1% | 6.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | 24.1% | 13.1% | 6.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.9 | 0.8 | 1.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 26,454 | 33,101 | 30,300 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
SolviMeda - Social security debts
The company had no debts to Sodra
SolviMeda - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2024-11-11 | 2024-11-18 | 484.62 |
| 2024-10-11 | 2024-10-13 | 7.67 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
SolviMeda, UAB (code 306167589) is a Private Limited Liability Company engaged in general medical practice activities. In the latest financial year 2025, the company generated revenue of €1.64M and net profit of €98.8K, with a profit margin of 6.0%. Revenue continued to expand strongly, rising by 68.3% year on year in 2025 and by 369.9% over two years, after reaching €973.7K in 2024 and €348.7K in 2023. Net profit also increased from €71.1K in 2023 to €127.7K in 2024, before easing in 2025, while remaining positive throughout the period. The balance sheet also grew, with total assets increasing to €652.7K in 2025 from €351.7K in 2024 and €138.2K in 2023. Equity stood at €260.1K and liabilities at €393.1K in 2025. Key ratios for 2025 show ROE of 38.0%, ROA of 15.1%, debt-to-equity of 1.51, and asset turnover of 2.51x. Revenue per employee was €30.3K, indicating a measurable operating scale.